AXON P/E Ratio Analysis
Updated 153h ago·SEC filings & market data
Key Takeaway
A P/E ratio of 229.2x means investors pay $229.20 for every $1 of the company's trailing earnings, reflecting a very high price relative to profit.
Sector Performance
99th percentileAXON
229.2x
Sector Median
23.1x
Sector Avg
33.7x
Prior Period
221.2x(Jul 2026)
Deep Analysis
A P/E ratio of 229.2x means investors pay $229.20 for every $1 of the company's trailing earnings, reflecting a very high price relative to profit.
For context, the sector median is 23.3x, placing AXON in the 99th percentile among peers—far more expensive than nearly all comparable stocks. The year-over-year change is not available, but quarter-over-quarter the P/E rose 3.6% from 221.2x to 229.2x. With the level already extreme and the trend moving higher, the valuation leaves little room for error: any earnings miss could trigger a sharp multiple contraction. This combination of a sky-high P/E and upward momentum signals elevated downside risk rather than a margin of safety. Therefore, this metric directly supports the overall CAUTIOUS verdict on the stock.
Frequently Asked Questions
What does the P/E Ratio tell investors about AXON?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are AXON's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: BROS (99.7x), WELL (102.4x), IAC (104.9x), FORM (108.1x), MCHP (113.5x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master AXON's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full AXON research report →AXON
229.2x
Sector Median
23.1x
Sector Avg
33.7x
How AXON's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.